On June 20, 2024, SAB Biotherapeutics, Inc. changed its name to SAB BIO.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.92 USD | +3.18% |
|
+5.42% | -57.53% |
06-20 | SAB Biotherapeutics, Inc. has Changed its Name to SAB BIO | CI |
06-07 | Brookline Capital Initiates SAB Biotherapeutics With Buy Rating, $8 Price Target | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.53% | 26.95M | |
+16.13% | 122B | |
+19.65% | 113B | |
+21.95% | 26.49B | |
-23.84% | 19.4B | |
-17.47% | 16.24B | |
-45.95% | 15.15B | |
-19.28% | 15.4B | |
+63.81% | 14.93B | |
+1.94% | 13.52B |
- Stock Market
- Equities
- SABS Stock
- News SAB Biotherapeutics, Inc.
- SAB Biotherapeutics, Inc. has Changed its Name to SAB BIO